Le Lézard
Classified in: Health, Science and technology, Business
Subject: LIC

Salvo Health and Lohman Technologies Redefine Connected Care for GI Chronic Conditions


The strategic partnership increases access to comprehensive care, monitoring and telehealth for those with chronic conditions, empowering better outcomes for patients and GI providers.

MILWAUKEE, March 21, 2024 /PRNewswire/ -- Lohman Technologies announced today its strategic partnership with Salvo Health, uniting to bring innovative solutions to market to empower patients with next-generation technologies for accessing care. The partnership is a testament to the shared vision of both companies in advancing digital connected care.

Salvo Health's mission is to radically increase access to interdisciplinary, "whole patient" care for those with GI and metabolic liver chronic conditions. The addition of Lohman's HomECG+ monitoring device to Salvo's wraparound care solution enables daily remote monitoring and support to the patient.

"Through our partnership with Salvo Health, we're revolutionizing GI healthcare for IBS patients," says Jason Dvorak, President of Lohman Technologies. "By leveraging Lohman's cutting-edge, FDA-cleared technology and our shared commitment to patient-centric care, we're poised to open up better care for the over 40 million Americans suffering from common GI conditions."

This collaborative effort aims to enable GI practices and health systems to bring in-home patient monitoring to patients who often need to manage conditions daily in the months between in-clinic appointments. Salvo's teams of registered dietitians, GI-trained nurses, and behavioral health specialists and tools leverage Lohman home devices as part of an evidence-based, personalized, outcome-focused, and cost-effective approach.

"With the integration of Lohman's solution, Salvo now has valuable information directly from the patient's fingertips daily, transmitted securely over cellular networks to their care team within minutes," says Jeff Glueck, Co-Founder and CEO of Salvo Health. "Our goal is to put the HomECG+ device into the hands of thousands of patients in the coming years. This will radically increase access to continuous, daily chronic care, all tightly coordinated under the supervision of the patient's trusted local physician."

About Salvo Health
Salvo Health focuses on enabling local providers across the country to provide wraparound care for chronic GI and metabolic liver conditions in a hybrid approach. Patients remain under the care of their trusted local physician, adding the best of Salvo telehealth and app-based daily support for follow-on care. To learn more about Salvo Health, visit their website at https://www.salvohealth.com.

About Lohman Technologies
Lohman's patented solution, HomECG+, ensures a direct connection between the patient and their healthcare providers, eliminating the need for a smartphone or WIFI technology. This not only enhances efficiency but also expands access to critical cardiac monitoring services. For more information, visit www.homecg.com.

SOURCE Lohman Technologies


These press releases may also interest you

at 10:05
The U.S. Army Educational Outreach Program (AEOP) announced that teams Momentum Charge (6th grade), The Water Project (7th grade), The Scientists (8th grade), and Team BioTech (9th grade) are the National Winners for their respective grade levels at...

at 10:05
Radionetics Oncology, a biotechnology company discovering and developing novel small molecule G protein coupled receptor (GPCR) targeted radiopharmaceuticals to treat a broad range of solid tumors, announced today the formation of a strategic...

at 10:01
According to a new industry report released by Fact.MR, the global soft tissue repair market size is expected to reach a size of US$ 7.39 billion in 2024 and further expand at 5.6% CAGR, to reach a value of US$ 12.78 billion by the end of 2034....

at 10:00
Economic activity in the manufacturing sector contracted in June for the third consecutive month and the 19th time in the last 20 months, say the nation's supply executives in the latest Manufacturing ISM® Report On Business®. The...

at 10:00
TOTAL Diversity Clinical Trial Management (TDCTM) With the release of the FDA draft guidance on June 26, 2024 the clock starts...

at 10:00
Neuroglee Health, a leading cognitive care solutions company,  announced today that it was selected to support patients and caregivers in the Center for Medicare and Medicaid Innovation's (CMMI's) Guiding an Improved Dementia Experience (GUIDE)...



News published on and distributed by: